Clinical Trials Logo

Filter by:
NCT ID: NCT02441959 Terminated - Clinical trials for Lumbar Disc Herniation

Full-Endoscopic vs Open Discectomy for the Treatment of Symptomatic Lumbar Herniated Disc

Start date: June 2015
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the clinical and radiographic outcomes of full endoscopic lumbar discectomy versus open lumbar decompression for the treatment of lumbar herniated discs in which the patient's leg pain is greater than back pain.

NCT ID: NCT02441517 Terminated - Clinical trials for Metastatic Castration Resistant Prostate Cancer

A Study of Enzalutamide Re-treatment in Metastatic Castration-resistant Prostate Cancer After Docetaxel and/or Cabazitaxel Treatment

Start date: October 28, 2015
Phase: Phase 4
Study type: Interventional

The purpose of the study was to understand if there is benefit in treatment with a medicine called enzalutamide in the re-treatment setting. Patients must have been previously treated with enzalutamide in the pre-chemotherapy setting for a minimum of 8 months and have disease progressed, followed by docetaxel and/or cabazitaxel for at least 4 cycles.

NCT ID: NCT02441140 Terminated - Clinical trials for Stage IV Ovarian Cancer

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Start date: May 2015
Phase: N/A
Study type: Interventional

This research study is studying a possible test which may help doctors diagnose women with ovarian cancer.

NCT ID: NCT02441101 Terminated - Heart Failure Clinical Trials

Right Ventricular Septal Pacing in Patients With Right Bundle Branch Block and Heart Failure (The SPARK Trial)

SPARK
Start date: February 1, 2016
Phase: N/A
Study type: Interventional

This clinical study has been designed to test whether a new pacing therapy would lead to improvement in heart function, symptoms and quality of life in a specific group of heart failure patients. This group has a unique electrical conduction problem (Right Bundle Branch Block) that did not respond well to the current available pacing therapy.

NCT ID: NCT02441036 Terminated - Skin Laxity Clinical Trials

Gene Expression Following Ultherapy® Treatment

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

Up to 25 subjects will be enrolled and randomized. Randomized subjects will receive one single-side Ulthera® treatment in the pre-auricular region on the face. At each subject's scheduled facelift procedure, resected tissue will be obtained for analysis.

NCT ID: NCT02440737 Terminated - Cancer Clinical Trials

Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers

NEST
Start date: May 2015
Phase: N/A
Study type: Interventional

This pilot clinical trial studies the Navigated Early Survivorship Transition (NEST) intervention in improving survivorship care planning in patients with newly diagnosed cancer and their caregivers. A survivorship care planning session (SCPS) delivered to survivors and their primary caregivers may improve psychosocial well-being, patient and caregiver engagement, and adherence to treatment and follow-up recommendations. It is not yet known whether a NEST intervention or usual care is better in improving survivorship care planning in patients with newly diagnosed cancer.

NCT ID: NCT02440685 Terminated - Cancer Clinical Trials

A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors

Start date: May 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This study is a dose escalation, and cohort expansion study in subjects with advanced cancer for which no standard therapy exists. Subjects must have received prior treatment for cancer that has not worked, or has stopped working.

NCT ID: NCT02440568 Terminated - Clinical trials for Acute Myeloid Leukemia

AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients

Start date: June 5, 2015
Phase: Phase 1/Phase 2
Study type: Interventional

This is a dose escalation study to evaluate Omacetaxine when given in combination with a standard induction regimen of "7+3" (cytarabine for Days 1-7 and Idarubicin for Days 1-3) in patients with newly diagnosed acute myelogenous leukemia (AML).

NCT ID: NCT02440529 Terminated - Clinical trials for Orthopaedic Decision Making

Surgeon-Patient Communication: A Randomized Controlled Trial Evaluating the Impact of an Orthopaedic Related Smoking Cessation Discussion After Fracture Surgery

Start date: January 2016
Phase: N/A
Study type: Interventional

In this study, the investigators are interested in evaluating the impact of an orthopaedic related smoking cessation discussion after fracture surgery.

NCT ID: NCT02439970 Terminated - Clinical trials for Cytomegalovirus Disease

A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease

SUSTAIN
Start date: September 2015
Phase: Phase 3
Study type: Interventional

To compare the efficacy of oral brincidofovir (BCV) to valganciclovir (vGCV) for the prevention of cytomegalovirus (CMV) disease in kidney transplant allograft recipients who are CMV seronegative pretransplant and received a kidney from a CMV seropositive donor